Veralto (VLTO) FY2024 10-K Annual Report

Filed: Feb 25, 2025
Health Care
Instruments For Meas & Testing of Electricity & Elec SignalsSEC EDGAR

Veralto (VLTO) 10-K annual report for fiscal year 2024, filed with SEC EDGAR on Feb 25, 2025. This page provides AI-powered analysis including business overview, management discussion & analysis (MD&A), risk factors, and key financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE) extracted from XBRL.

Veralto FY2024 10-K Analysis

Business Overview

  • Core business model: global industrial and consumer product sales with geographic and industry diversity
  • Emphasis on acquisitions, investments, strategic partnerships to drive innovation and higher margin products
+3 more insights

Risk Factors

  • Indemnification liability risk with significant deductible on director/officer insurance coverage potentially exceeding insured amounts
  • Goodwill impairment sensitivity with reporting unit fair values 144%-783% above carrying value after hypothetical 10% valuation decrease
+3 more insights

Veralto FY2024 Key Financial Metrics
XBRL

Revenue

$5.2B

+3.4% YoY

Net Income

$833M

-0.7% YoY

Gross Margin

59.8%

+201bp YoY

Operating Margin

23.3%

+56bp YoY

Net Margin

16.0%

-67bp YoY

ROE

40.9%

-1979bp YoY

Total Assets

$6.4B

+12.5% YoY

EPS (Diluted)

$3.34

-1.8% YoY

Operating Cash Flow

$875M

-9.1% YoY

Source: XBRL data from Veralto FY2024 10-K filing on SEC EDGAR. All figures in USD.

Other Veralto Annual Reports

Get deeper insights on Veralto

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.